| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Higgons John Duncan is a Chief Operating Officer at AGIOS PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $4.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2015 | AGIO Agios Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 20,000 | $50.09 | $1,001,800.00 | -24.4% | |
| Nov 16, 2015 | AGIO Agios Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 20,000 | $61.51 | $1,230,200.00 | -19.6% | |
| Oct 15, 2015 | AGIO Agios Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 20,000 | $71.04 | $1,420,800.00 | -19.6% | |
| Sep 15, 2015 | AGIO Agios Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 20,000 | $91.11 | $1,822,200.00 | -12.4% | |
| Aug 17, 2015 | AGIO Agios Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 20,000 | $92.24 | $1,844,800.00 | -13.2% | |
| Jul 16, 2015 | AGIO Agios Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 20,000 | $114.02 | $2,280,400.00 | -14.1% | |
| Jun 15, 2015 | AGIO Agios Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 7,000 | $105.23 | $736,610.00 | -5.4% | |
| May 15, 2015 | AGIO Agios Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 7,417 | $112.89 | $837,305.13 | -7.0% |